164 related articles for article (PubMed ID: 1719081)
21. Temporal loss of Nef-epitope CTL recognition following macaque lipopeptide immunization and SIV challenge.
Mortara L; Letourneur F; Villefroy P; Beyer C; Gras-Masse H; Guillet JG; Bourgault-Villada I
Virology; 2000 Dec; 278(2):551-61. PubMed ID: 11118377
[TBL] [Abstract][Full Text] [Related]
22. Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model.
Earl PL; Wyatt LS; Montefiori DC; Bilska M; Woodward R; Markham PD; Malley JD; Vogel TU; Allen TM; Watkins DI; Miller N; Moss B
Virology; 2002 Mar; 294(2):270-81. PubMed ID: 12009868
[TBL] [Abstract][Full Text] [Related]
23. Recombinant Mycobacterium bovis BCG vector system expressing SIV Gag protein stably and persistently induces antigen-specific humoral immune response concomitant with IFN gamma response, even at three years after immunization.
Kawahara M
Clin Immunol; 2008 Dec; 129(3):492-8. PubMed ID: 18849196
[TBL] [Abstract][Full Text] [Related]
24. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
[TBL] [Abstract][Full Text] [Related]
25. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
26. Detailed analysis of CD4+ Th responses to envelope and Gag proteins of simian immunodeficiency virus reveals an exclusion of broadly reactive Th epitopes from the glycosylated regions of envelope.
Sarkar S; Kalia V; Murphey-Corb M; Montelaro RC
J Immunol; 2002 Apr; 168(8):4001-11. PubMed ID: 11937557
[TBL] [Abstract][Full Text] [Related]
27. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
[TBL] [Abstract][Full Text] [Related]
28. Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells.
Hammond SA; Obah E; Stanhope P; Monell CR; Strand M; Robbins FM; Bias WB; Karr RW; Koenig S; Siliciano RF
J Immunol; 1991 Mar; 146(5):1470-7. PubMed ID: 1704395
[TBL] [Abstract][Full Text] [Related]
29. Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
Martinon F; Gras-Masse H; Boutillon C; Chirat F; Deprez B; Guillet JG; Gomard E; Tartar A; Levy JP
J Immunol; 1992 Nov; 149(10):3416-22. PubMed ID: 1385524
[TBL] [Abstract][Full Text] [Related]
30. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
Hulskotte EG; Geretti AM; Siebelink KH; van Amerongen G; Cranage MP; Rud EW; Norley SG; de Vries P; Osterhaus AD
J Virol; 1995 Oct; 69(10):6289-96. PubMed ID: 7666529
[TBL] [Abstract][Full Text] [Related]
31. Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC types.
Berzofsky JA; Pendleton CD; Clerici M; Ahlers J; Lucey DR; Putney SD; Shearer GM
J Clin Invest; 1991 Sep; 88(3):876-84. PubMed ID: 1715888
[TBL] [Abstract][Full Text] [Related]
32. Vaccination of rhesus monkeys with synthetic peptide in a fusogenic proteoliposome elicits simian immunodeficiency virus-specific CD8+ cytotoxic T lymphocytes.
Miller MD; Gould-Fogerite S; Shen L; Woods RM; Koenig S; Mannino RJ; Letvin NL
J Exp Med; 1992 Dec; 176(6):1739-44. PubMed ID: 1460429
[TBL] [Abstract][Full Text] [Related]
33. CD8+ cytotoxic T lymphocytes of a cynomolgus macaque infected with simian immunodeficiency virus (SIV) mac32H-J5 recognize a nine amino acid epitope in SIV Gag p26.
Geretti AM; Hulskotte EG; Dings ME; van Baalen CA; van Amerongen G; Osterhaus AD
J Gen Virol; 1997 Apr; 78 ( Pt 4)():821-4. PubMed ID: 9129654
[TBL] [Abstract][Full Text] [Related]
34. Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.
Israel ZR; Edmonson PF; Maul DH; O'Neil SP; Mossman SP; Thiriart C; Fabry L; Van Opstal O; Bruck C; Bex F
J Virol; 1994 Mar; 68(3):1843-53. PubMed ID: 8107246
[TBL] [Abstract][Full Text] [Related]
35. A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
Yasutomi Y; Koenig S; Woods RM; Madsen J; Wassef NM; Alving CR; Klein HJ; Nolan TE; Boots LJ; Kessler JA
J Virol; 1995 Apr; 69(4):2279-84. PubMed ID: 7884874
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 env, nef, and gag-specific T-cell immunity in mice: conserved epitopes in nef p27 and gag p25 proteins.
Michel F; Hoffenbach A; Froussard P; Langlade-Demoyen P; Kaczorek M; Kieny MP; Plata F
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):469-78. PubMed ID: 1376136
[TBL] [Abstract][Full Text] [Related]
37. Enhanced cellular immune responses to SIV Gag by immunization with influenza and vaccinia virus recombinants.
Nakaya Y; Zheng H; García-Sastre A
Vaccine; 2003 May; 21(17-18):2097-106. PubMed ID: 12706700
[TBL] [Abstract][Full Text] [Related]
38. Abrogation of AIDS vaccine-induced cytotoxic T-lymphocyte efficacy in vivo due to a change in viral epitope flanking sequences.
Moriya C; Igarashi H; Takeda A; Tsukamoto T; Kawada M; Yamamoto H; Inoue M; Iida A; Shu T; Hasegawa M; Nagai Y; Matano T
Microbes Infect; 2008 Mar; 10(3):285-92. PubMed ID: 18316225
[TBL] [Abstract][Full Text] [Related]
39. Recombinant virus vaccine-induced SIV-specific CD8+ cytotoxic T lymphocytes.
Shen L; Chen ZW; Miller MD; Stallard V; Mazzara GP; Panicali DL; Letvin NL
Science; 1991 Apr; 252(5004):440-3. PubMed ID: 1708168
[TBL] [Abstract][Full Text] [Related]
40. Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus.
Dittmer U; Feldmann G; Sauermann U; Spirng M; Uberla K; Stahl-Hennig C; Hunsmann G
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1801-7. PubMed ID: 9680145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
